UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $202
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $180 to $202.
UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $180 to $202.